Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma.

Gu TL, Deng X, Huang F, Tucker M, Crosby K, Rimkunas V, Wang Y, Deng G, Zhu L, Tan Z, Hu Y, Wu C, Nardone J, MacNeill J, Ren J, Reeves C, Innocenti G, Norris B, Yuan J, Yu J, Haack H, Shen B, Peng C, Li H, Zhou X, Liu X, Rush J, Comb MJ.

PLoS One. 2011 Jan 6;6(1):e15640. doi: 10.1371/journal.pone.0015640.

2.

Molecular pathways: ROS1 fusion proteins in cancer.

Davies KD, Doebele RC.

Clin Cancer Res. 2013 Aug 1;19(15):4040-5. doi: 10.1158/1078-0432.CCR-12-2851. Epub 2013 May 29. Review.

3.

The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer.

Acquaviva J, Wong R, Charest A.

Biochim Biophys Acta. 2009 Jan;1795(1):37-52. doi: 10.1016/j.bbcan.2008.07.006. Epub 2008 Aug 3. Review.

PMID:
18778756
4.

ROS receptor tyrosine kinase: a new potential target for anticancer drugs.

El-Deeb IM, Yoo KH, Lee SH.

Med Res Rev. 2011 Sep;31(5):794-818. doi: 10.1002/med.20206. Epub 2010 Aug 4. Review.

PMID:
20687158

Supplemental Content

Write to the Help Desk